Duxin Sun – The Conversation

A high drug failure rate is more than just a pattern recognition problem. Thom Leach/Science Photo Library via Getty Images

January 3, 2025

Will AI revolutionize drug development? Researchers explain why it depends on how it’s used

Duxin Sun, University of Michigan and Christian Macedonia, University of Michigan

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and effective drugs.

Nanoparticles can help cancer drugs home in on tumors and avoid damaging healthy cells. Kateryna Kon/Science Photo Library via Getty Images

May 4, 2022

Nanoparticles are the future of medicine – researchers are experimenting with new ways to design tiny particle treatments for cancer

Duxin Sun, University of Michigan

The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet, better design could help fulfill its promise.

The majority of drug failures are attributed to lack of clinical efficacy and high toxicity. Andrew Brookes/Image Source via Getty Images

February 23, 2022

90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates

Duxin Sun, University of Michigan

Drug development is a long and costly process that often ends in failure. Improving the way potential drug candidates are optimized could help boost success rates.

Contact Duxin for